Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
OTC Chitosan Gel (ANX-011): A Nasal Gel Formulation for Cold and Flu Treatment that is Commercially Ready More
Bilosomes: A Novel Technology for Oral Vaccine Delivery More
Clinical Development of a Novel Vaccine Adjuvant and Delivery System: CAP (Calcium Phosphate) Nanoparticles More
The Lauriad® Drug Delivery Technology in Clinical Trials for the Treatment of Oropharyngeal Candidiasis, Labial Herpes and Cancer Pain More
Positive Top Line Results of a Clinical Trial of IFN-alpha-XL versus PegIntron™ in Patients with Chronic Hepatitis C Virus Infection More
Development of a Novel Treatment of Bedsores and Other Dermal Ulcers: A Spray Formulation Containing Recombinant Human Basic Fibroblast Growth Factor More
Virosome Technology: Target-Specific Delivery of Antigens and Amplification of the Immune Response More
Method for Inhibiting Angiogenesis using Heparinase More
Improving the use of VIP as a Therapeutic: Liposome and Micelle Preparations to Improve Drug Efficacy More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 11 pages - $500
Mar 2010 - 414 pages - $690
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Feb 2009 - 242 pages - $690
Jun 2011 - 16 pages - $500
Apr 2010 - 23 pages - $99
May 2011 - 10 pages - $500
Apr 2010 - 5 pages - $500
Apr 2011 - 11 pages - $500
Your selection
Browse By
- Therapeutic target
- Allergic rhinitis (hay fever)
- Allergies (other)
- Allergy, ophthalmic
- Allergy, skin
- Anaphylaxis
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us